Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer

被引：0
|
作者：
Powles, Thomas
Sharpe, Kevin
Berney, Dan
Kayani, Irfan
Doshi, Rukma
Stewart, Grant Duncan
Reynolds, Andrew
Bex, Axel
Sarwar, Naveed
Chowdhury, Simon
机构：
[1] Barts Canc Inst, London, England
[2] Univ Colorado Hosp, London, England
[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[4] Inst Canc Res, London SW3 6JB, England
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Guys & St Thomas NHS Fdn Trust, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
437
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Second-Line Therapy After VEGF Targeted Therapy in Metastatic Renal Cancer: A Law of Diminishing Returns
    Powles, Thomas
    CLINICAL GENITOURINARY CANCER, 2012, 10 (02) : 67 - 68
  • [32] A PHASE I DOSE ESCALATION STUDY INVESTIGATING DOVITINIB AND EVEROLMUS IN COMBINATION IN METASTATIC CLEAR CELL RENAL CANCER PATIENTS WHO HAVE PREVIOUSLY FAILED VEGF TARGETED THERAPY
    Powles, T. B.
    Jones, R. J.
    Crabb, S.
    Sarker, S.
    Boleti, E.
    Shamash, J.
    Sarwar, N.
    Chowdhury, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 272 - 272
  • [33] PRadR: PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer, a multicentric phase I/II
    Vinceneux, Armelle
    Bidaux, Anne-Sophie
    Cropet, Claire
    Tatu, Delphine
    Bernardin, Mathilde
    Neymarc, Severine
    Perol, David
    Pouget, Jean-Pierre
    Constanzo, Julie
    Foray, Nicolas
    Djaileb, Loic
    Kelly, Antony
    Kryza, David
    Giraudet, Anne-Laure
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Yasser Ged
    Ruby Gupta
    Cihan Duzgol
    Andrea Knezevic
    Natalie Shapnik
    Ritesh Kotecha
    Martin H. Voss
    Darren R. Feldman
    Oguz Akin
    Sujata Patil
    Robert J. Motzer
    Brian I. Rini
    Chung-Han Lee
    BMC Urology, 20
  • [35] Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Ged, Yasser
    Gupta, Ruby
    Duzgol, Cihan
    Knezevic, Andrea
    Shapnik, Natalie
    Kotecha, Ritesh
    Voss, Martin H.
    Feldman, Darren R.
    Akin, Oguz
    Patil, Sujata
    Motzer, Robert J.
    Rini, Brian, I
    Lee, Chung-Han
    BMC UROLOGY, 2020, 20 (01)
  • [36] COMPARATIVE EFFECTIVENESS OF FIRST-LINE IMMUNOTHERAPY, TARGETED THERAPY, AND COMBINATION THERAPY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA
    Chakiryan, Nicholas
    Jiang, David
    Gillis, Kyle
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Chahoud, Jad
    Zhang, Jingsong
    Jain, Rohit
    Sexton, Wade
    Gilbert, Scott
    Manley, Brandon
    JOURNAL OF UROLOGY, 2021, 206 : E678 - E678
  • [37] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
  • [38] The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database
    Koguchi, Tomoyuki
    Naito, Sei
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Muto, Yumina
    Kato, Renpei
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Morozumi, Kento
    Kandori, Shuya
    Kawamura, Sadafumi
    Nishiyama, Hiroyuki
    Ito, Akihiro
    Habuchi, Tomonori
    Obara, Wataru
    Ohyama, Chikara
    Tsuchiya, Norihiko
    Kojima, Yoshiyuki
    CANCER MEDICINE, 2023, 12 (22): : 20677 - 20689
  • [39] Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
    Golijanin, Borivoj
    Malshy, Kamil
    Khaleel, Sari
    Lagos, Galina
    Amin, Ali
    Cheng, Liang
    Golijanin, Dragan
    Mega, Anthony
    CANCER TREATMENT REVIEWS, 2023, 121
  • [40] Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): What next?
    Vickers, M. M.
    Choueiri, T. K.
    Zama, I.
    Cheng, T.
    North, S.
    Knox, J. J.
    Kollmannsberger, C.
    McDermott, D. F.
    Rini, B. I.
    Heng, D. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345